6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole PurCert Secondary Working Standard [Includes all characterization data]
CRM
Properties
| Assay Purity | >=99% |
| B pt. | 359 °C |
| M pt. | 59 - 64 °C |
| Density | 1.216 g/cm3 |
| Form | Liquid |
Safety Information
| Hazard Statement(s) | H301-H315-H319-H335 |
| Precautionary Statement | P261 - P264 - P271 - P301 + P310 - P302 + P352 - P305 + P351 + P338 |
| GHS Pictogram |
|
| Signal word | Danger |
| HS Code | 98020000 |
| Storage Temp. | Room Temperature |
| UN Number | NA |
Description
Application
Key intermediate in pharmaceutical manufacturing. Used in the synthesis of antipsychotic and central nervous system (CNS) agents. Research and development of new medicinal compounds. Organic synthesis involving heterocyclic chemistry.
Purpose
Serves as a precursor for the preparation of active pharmaceutical ingredients (APIs). Provides the benzisoxazole-piperidine structural framework required for biologically active molecules. Used in medicinal chemistry research to develop compounds with CN
General Description
6-Fluoro-3-(4-piperidinyl)-1 2-benzisoxazole is a fluorinated benzisoxazole derivative containing a piperidine ring. It is an important pharmaceutical intermediate used in the synthesis of several biologically active compounds particularly antipsychotic drugs.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form | |
| Sample COA |
